Limelight Bio, Inc.

LIMELIGHT

Gene therapy products, namely, therapeutics for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders, all of the above excluding lyme disease;Research and development of human therapeutics; biopharmaceutical research and development services;